XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 01, 2022
Mar. 02, 2020
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock, shares issued     4,073,757   4,073,757   2,823,072
Common stock, shares outstanding     4,073,757   4,073,757   2,823,072
Stock issued during period shares new issues         $ 5,740,758    
Warrant to purchase of shares of common stock     124,258 0 124,258 0  
Fair value of warrants issued price per share     $ 3.91   $ 3.91    
Amortization of deferred financing costs         $ 155,667 $ 77,804  
Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Private placement agent 8.00% 8.00%          
Debt issuance costs   $ 175,924          
Underwriting expense   307,867          
Amortization of deferred financing costs     $ 25,935 $ 25,935 77,804 $ 77,804  
Private placement offering   $ 440,000          
Accredited Investors [Member] | 12% Subordinated Notes [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock issued during period, shares   80,000          
Number of shares sold   2,000          
Sale of stock price per share   $ 1,000          
Value of stock sold   $ 1,000          
Conversion of units, shares   40          
Conversion of units   $ 2,000,000          
Accredited Investors [Member] | Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock issued during period, shares   875,000          
Price per share   $ 4.00          
Number of shares sold   955,000          
Proceeds from private placement   $ 3,500,000          
Securities Purchase Agreement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Placement agent cash     254,160   254,160    
Underwriting expense         492,181    
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Placement agent cash $ 696,420            
Warrant to purchase of shares of common stock 124,258            
Class of warrant or right, exercise price of warrants or rights $ 4.62            
Debt issuance costs $ 165,406   $ 47,607   $ 47,607    
Fair value of warrants issued price per share     $ 3.91   $ 3.91    
Amortization of deferred financing costs     $ 38,931   $ 77,862    
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member] | Minimum [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Class of warrant or right, exercise price of warrants or rights $ 3.30            
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member] | Maximum [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Class of warrant or right, exercise price of warrants or rights $ 3.97            
Securities Purchase Agreement [Member] | Private Placement [Member] | 12% Subordinated Notes [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock issued during period, shares 2,964,500            
Stock issued during period shares new issues $ 8,705,256            
Securities Purchase Agreement [Member] | Accredited Investors [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of stock issued during period, shares 1,242,588            
Price per share $ 4.62            
Stock issued during period shares new issues $ 5,740,756            
2015 Equity Incentive Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock capital shares reserved for future issuance     497,330   497,330    
Exercise of Outstanding Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock capital shares reserved for future issuance     255,958   255,958    
Warrant [Member] | Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant to purchase of shares of common stock   95,500 95,500   95,500    
Class of warrant or right, exercise price of warrants or rights   $ 4.00 $ 4.00   $ 4.00    
Debt issuance costs   $ 135,291          
Fair value of warrants issued price per share   $ 3.90          
Underwriting expense   $ 236,761          
Warrants term   5 years          
Warrant exercisable date         Mar. 30, 2027    
Warrant One [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant to purchase of shares of common stock     3,000   3,000    
Class of warrant or right, exercise price of warrants or rights     $ 15.00   $ 15.00    
Warrant exercisable date         Mar. 30, 2027    
Warrant Two [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant to purchase of shares of common stock     17,200   17,200    
Class of warrant or right, exercise price of warrants or rights     $ 12.50   $ 12.50    
Warrant exercisable date         Mar. 30, 2027    
Warrant Three [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant to purchase of shares of common stock     16,000   16,000    
Class of warrant or right, exercise price of warrants or rights     $ 9.00   $ 9.00    
Warrant exercisable date         Mar. 30, 2027    
Warrant Member One [Member] | Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Warrant to purchase of shares of common stock     124,258   124,258    
Class of warrant or right, exercise price of warrants or rights     $ 4.62   $ 4.62    
Warrant exercisable date         Mar. 30, 2027